BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cerexa, Inc. 

2100 Franklin Street
Suite 900
Oakland  California  94612  U.S.A.
Phone: 510-285-9200 Fax: 510-747-3940


SEARCH JOBS










 Company News
Forest Laboratories, Inc. (FRX) Announces Completion of Acquisition Of Cerexa, Inc. 1/12/2007 8:38:12 AM    More...
The Day In Review: Forest Laboratories, Inc. (FRX) Buys Cerexa, Inc. For $480 Million 12/15/2006 12:25:33 PM    More...
Cerexa, Inc. Expands Portfolio Of Novel Anti-Infective Therapies Through In-Licensing Agreement With Meiji Seika Kaisha, Ltd. 11/1/2006 12:24:23 PM    More...
Cerexa, Inc. Release: Phase 2 Study Shows Ceftaroline Highly Efficacious In Treatment Of cSSSI Compared To Standard Therapy 9/29/2006 2:11:06 PM    More...
Cerexa, Inc. Reports Positive Top-Line Results For Phase 2 Clinical Trial Of Ceftaroline 8/2/2006 10:23:45 AM    More...
Cerexa, Inc. Appoints George H. Talbot, M.D., Chief Medical Officer, Executive Vice President 7/28/2006 10:39:52 AM    More...
Cerexa, Inc. Announces Completion Enrollment In Ceftaroline Phase 2 Trial 4/5/2006 10:24:09 AM    More...
FDA Grants Cerexa, Inc. Fast Track Designation For PPI-0903 3/14/2006 10:31:17 AM    More...
East Bay Biotechs Hit Sales Block 1/3/2006 11:44:06 AM    More...
Cerexa, Inc. To Present At Credit Suisse First Boston Healthcare Conference 11/15/2005 12:19:49 PM    More...
12